The aim of this study was to evaluate which angiotensin type @ receptor blockers ( ARBs ) , telmisartan or candesartan , is superior for the control of home blood pressure ( BP ) in the morning when the outpatient clinic BP was well controlled in the patients with metabolic syndrome .